Lund University
Medical Radiation Physics
Final-year PhD student in Medical Physics at Lund University. My research focus is to prepare the electron beam of our modified Elekta linear accelerator for clinical FLASH trials. The projects cover dosimetric and technical developments to allow for safe and accurate delivery of ultra-high dose rates, as well as the treatment of canine cancer patients to investigate the clinical benefit of FLASH.

Moderator of 1 Session

FLASH in Pre-Clinical and Clinical Settings
Session Type
FLASH in Pre-Clinical and Clinical Settings
Date
30.11.2022
Session Time
17:05 - 17:35
Room
Hall 113-114

Presenter of 1 Presentation

IMPROVED DOSE DISTRIBUTION FOR ELECTRON FLASH RADIOTHERAPY WITH OPTIMIZED-THICKNESS BOLUS AND INTENSITY MODULATION

Session Type
FLASH in Pre-Clinical and Clinical Settings
Date
30.11.2022
Session Time
17:40 - 18:40
Room
Hall 131-132
Lecture Time
18:16 - 18:25

Abstract

Background and Aims

In electron radiotherapy, heterogenous dose distribution is a common problem resulting from complex surfaces and tissue inhomogeneities. For the high-dose single-fractions commonly used in FLASH radiotherapy (FLASH-RT), this must be carefully considered. In this study we evaluate Bolus Electron Conformal Therapy (BECT) for FLASH-RT. The specific aim was to evaluate if optimized-thickness bolus and intensity modulation can reduce dose heterogeneities in high-dose single-fraction treatments to be used in a veterinary clinical trial in canine cancer patients.

Methods

In the treatment planning system electronRT (.decimalĀ®, LLC, Sanford, Florida, USA), CT-based treatment planning can be utilized to design and subsequently fabricate individualized 3D bolus in machinable wax. Furthermore, the beams can be intensity modulated using tungsten pins in the electron block cut-out. To evaluate if optimized-thickness bolus and intensity modulation could reduce cold- and hotspots and improve the target dose homogeneity, treatment plans employing these two methods were created in a canine cancer patient case with a simulated superficial nasal tumor. The prescribed dose was 30 Gy to 95% of the CTV, and a circular field with a diameter of 6.5 cm was used.

Results

By adding optimized-thickness bolus to the canine patient treatment plan, the maximum relative dose was decreased from 143% to 116%, and the CTV homogeneity index (HI) was reduced from 0.30 to 0.15 (Figure 1). By adding intensity modulation, the HI could be further reduced to 0.10.

figure.png

Conclusions

We have evaluated the potential of optimized-thickness bolus and intensity modulation for FLASH-RT. We found that unwanted hot spots in heterogenous tissue could effectively be reduced in a canine patient treatment plan. Next, we will verify that these plans can be accurately delivered. This technique will help us avoid overdosing and possibly related toxicity in future clinical studies with electron FLASH-RT.

Hide